GYRE
Gyre Therapeutics Inc.
7.10$
+1.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 10.7% | 30.2% | 5.3% | 40.8% | 1.7% | 6.2% | 3.7% | 2.8% | 2.3% | 2.5% | – | 180.7% | 290.5% | 340.5% | 2,645.4% | 17.0% | 2,483.3% | – | 43.7% | 104.5% | 4.7% | 4.1% | 3.7% | 4.6% | |
| 100.0% | 89.3% | 69.8% | 94.7% | 59.2% | 98.3% | 93.8% | 96.3% | 97.2% | 97.7% | 97.5% | 100.0% | -80.7% | -190.5% | -240.5% | -2,545.4% | 83.0% | -2,383.3% | – | 56.3% | -4.5% | 95.3% | 95.9% | 96.3% | 95.4% | |
| 478.7% | 710.6% | 739.6% | 609.1% | 2,055.4% | 79.1% | 299.1% | 204.0% | 160.3% | 75.3% | 97.5% | 84.8% | 1,070.3% | 290.5% | 340.5% | 2,896.0% | 1,262.0% | 357,900.0% | – | 252.9% | 880.0% | 16.3% | 12.1% | 11.4% | 11.7% | |
| – | – | – | – | – | 20,684.9% | 69,217.7% | 32.4% | 32.6% | 9.4% | 12.5% | 22.8% | 330.8% | 223.7% | 548.2% | 2,321.3% | 981.6% | 205,900.0% | – | 77.2% | 256.5% | 17.0% | 12.9% | 15.2% | 17.8% | |
| 613.9% | 1,008.1% | 886.0% | 747.2% | 2,596.8% | 99.8% | 368.3% | 236.4% | 258.1% | 82.4% | 107.4% | 107.6% | 1,401.1% | 476.7% | 888.7% | 5,217.3% | 2,226.6% | 563,800.0% | – | 330.1% | 1,136.5% | 86.3% | 155.2% | 81.0% | 85.5% | |
| -513.9% | -918.8% | -816.3% | -652.5% | -2,537.5% | -1.5% | -274.5% | -140.1% | -160.9% | 15.3% | -10.0% | -8.4% | -1,301.1% | -414.2% | -788.7% | -5,117.3% | -2,143.6% | -563,700.0% | – | -273.9% | -1,141.0% | 9.0% | -59.3% | 15.3% | 9.9% | |
| – | – | – | 3.6% | 19.1% | 0.3% | 1.2% | 1.2% | 0.9% | 0.2% | 0.1% | 0.1% | 1.5% | 1.3% | 84.5% | – | – | – | – | – | 3.0% | 0.7% | – | – | – | |
| – | – | – | -642.7% | -2,457.1% | 7.6% | -242.5% | -127.8% | -157.6% | 16.8% | -8.7% | -12.3% | -1,286.8% | -364.8% | -843.5% | -4,246.9% | -2,118.0% | -500,916.7% | – | -268.5% | -1,198.3% | 9.2% | -67.8% | 22.0% | 12.4% | |
| 428.8% | 921.8% | 789.1% | -9.8% | -80.5% | -9.1% | -32.0% | -21.3% | -0.4% | 4.1% | -2.5% | -0.2% | 0.2% | 192.2% | 29.6% | 772.9% | -17.0% | 62,783.3% | – | -3.3% | -0.5% | 5.0% | 7.5% | 5.0% | 3.9% | |
| -428.8% | -921.8% | -789.1% | -642.7% | -2,457.1% | 7.6% | -242.5% | -127.8% | -157.2% | 12.7% | -8.7% | -12.1% | -1,287.0% | -1,799.4% | -843.5% | -4,246.9% | -2,118.0% | -500,916.7% | – | -265.1% | -1,198.3% | 2.3% | -81.9% | 11.4% | 4.3% | |
| -513.9% | -918.8% | -816.3% | -618.6% | -2,469.5% | 1.5% | -266.6% | -131.2% | -153.6% | 17.6% | -7.4% | -4.6% | -1,288.6% | -376.7% | -732.2% | -5,019.8% | -2,126.6% | -563,700.0% | – | -267.8% | -1,194.4% | 10.3% | 17.9% | 16.8% | 14.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.